ArticleWorld journal of clinical oncology2022

Molecular docking of DS-3032B, a mouse double minute 2 enzyme antagonist with potential for oncology treatment development.

Vítor Hugo Sales da Mota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.